Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valsasina, P.
Right arrow Articles by Filippi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valsasina, P.
Right arrow Articles by Filippi, M.
Related Collections
Right arrow MRI
Right arrow Volumetric MRI
Right arrow Multiple sclerosis
NEUROLOGY 2005;65:1126-1128
© 2005 American Academy of Neurology
Brief Communications

Evidence for progressive gray matter loss in patients with relapsing-remitting MS

P. Valsasina, PhD, B. Benedetti, MD, M. Rovaris, MD, M. P. Sormani, PhD, G. Comi, MD and M. Filippi, MD

From the Neuroimaging Research Unit (Drs. Valsasina, Benedetti, Rovaris, and Filippi), Department of Neurology (Drs. Benedetti, Rovaris, Comi, and Filippi), Scientific Institute and University H San Raffaele, Milan; and Unit of Clinical Epidemiology (Dr. Sormani), National Cancer Institute, Genoa, Italy.

Address correspondence and reprint requests to Dr. Massimo Filippi, Neuroimaging Research Unit, Department of Neurology, Scientific Institute and University H San Raffaele, Via Olgettina 60, 20132 Milan, Italy; e-mail: filippi.massimo{at}hsr.it.

Little is known about the temporal evolution of gray matter damage occurring early in the course of multiple sclerosis (MS). The authors investigated the evolution of gray matter volume loss in 117 patients with relapsing–remitting MS, scanned monthly for a 9-month period. Time-trend analysis revealed a decrease of gray matter volumes over the study period (p < 0.001). This study shows that gray matter damage in relapsing–remitting MS evolves markedly over a short period of observation.

Disclosure: M. Filippi, MD, G. Comi, MD, M. Rovaris, MD, and M.P. Sormani, PhD, received honoraria—M. Filippi and G. Comi's honoraria exceeded $10,000—from TEVA for their participation in the MRI-monitored European/Canadian glatiramer acetate trial. This study is based on the placebo data of the above-mentioned trial but was conducted independently and without any sponsorship.

Received April 1, 2005. Accepted in final form June 16, 2005.




This article has been cited by other articles:


Home page
 Arch NeurolHome page
Z. Khaleeli, D. R. Altmann, M. Cercignani, O. Ciccarelli, D. H. Miller, and A. J. Thompson
Magnetization Transfer Ratio in Gray Matter: A Potential Surrogate Marker for Progression in Early Primary Progressive Multiple Sclerosis
Arch Neurol, November 1, 2008; 65(11): 1454 - 1459.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
D Bar-Zohar, F Agosta, D Goldstaub, and M Filippi
Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives
Multiple Sclerosis, July 1, 2008; 14(6): 719 - 727.
[Abstract] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
D Horakova, J L Cox, E Havrdova, S Hussein, O Dolezal, D Cookfair, M G Dwyer, Z Seidl, N Bergsland, M Vaneckova, et al.
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study
J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 407 - 414.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Mesaros, M. A. Rocca, M. Absinta, A. Ghezzi, N. Milani, L. Moiola, P. Veggiotti, G. Comi, and M. Filippi
Evidence of thalamic gray matter loss in pediatric multiple sclerosis
Neurology, March 25, 2008; 70(13_Part_2): 1107 - 1112.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. Zivadinov
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
Neurology, May 29, 2007; 68(22_suppl_3): S72 - S82.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
R. Zivadinov, L. Locatelli, D. Cookfair, B. Srinivasaraghavan, A. Bertolotto, M. Ukmar, A. Bratina, C. Maggiore, A. Bosco, A. Grop, et al.
I nterferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy
Multiple Sclerosis, May 1, 2007; 13(4): 490 - 501.
[Abstract] [PDF]

Home page
 BrainHome page
F. Agosta, M. Rovaris, E. Pagani, M. P. Sormani, G. Comi, and M. Filippi
Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis
Brain, October 1, 2006; 129(10): 2620 - 2627.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
C. Oreja-Guevara, A. Charil, D. Caputo, R. Cavarretta, M. P. Sormani, and M. Filippi
Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
Arch Neurol, May 1, 2006; 63(5): 736 - 740.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.